The intestinal epithelium is a highly dynamic barrier that regulates digestion, absorption, immune responses, and ...

A noteworthy case study. What caused a 43-year-old woman to develop lesions all over her body that were not only extremely ...

[5] After exclusions of such diseases as infectious colitis, bacillary dysentery, amebiasis, chronic schistosomiasis, intestinal tuberculosis, Crohn's disease, ischemic colitis and radiation ...

Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solution ...

Dr K Geboes, Department of Pathology, University Hospital, KULeuven, Minderbroedersstraat 12, 3000 Leuven, Belgium. Email: Karel.Geboes{at}uz.kuleuven.ac.be BACKGROUND Evaluation of histological ...

Ulcerative colitis (UC), characterized by disrupted intestinal barrier ... confers multi-target protective effects in experimental colitis and associated hepatic pathology, warranting further ...

1 MRC Microbiology and Gut Biology Group, University of Dundee, Dundee, UK 2 Department of Molecular and Cellular Pathology, University of Dundee ... These bacteria have previously been linked to ...

Other comorbidities that could justify the pathology. • Other drugs/ toxics that ... A differential diagnosis should also be considered with IBD [Ulcerative colitis/Chron’s Disease (UC/CD)], as ...

SAN FRANCISCO -- Research presented at the annual Crohn's and Colitis Congress included studies comparing the effectiveness ...

Low-fiber fruits and vegetables, lean proteins, and foods rich in omega-3 fatty acids tend to be easier on an inflamed gut, ...

In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...